Standard cost-effectiveness analyses compare the investment made in a programme to its HIV benefit alone. But by intervening “upstream”, structural programmes are likely to have multiple other health and development objectives and benefits. Evaluating the value-for-money of this kind of intervention therefore requires a broad cross-sectoral perspective. The HIV sector could, for example, co-finance such interventions with other benefiting sectors. In this scenario, value-for-money would be assessed on the contribution of each sector, rather than on the full cost of the intervention.
Remme, M. STRIVE Learning Lab 26. Breaking down financing silos: the potential of co-financing. (2014) 35 min.